動物用医薬品の世界市場の機会と2032年までの戦略以下1) タイプ別動物用ワクチン、動物用抗生物質、動物用寄生虫駆除剤2) 投与経路別：経口剤; 非経口剤; 局所剤3) 動物の種類別：家畜; 飼育動物4) ワクチンタイプ別：不活化ワクチン; 急性化ワクチン; 遺伝子組換えワクチン5) エンドユーザー別: 動物病院; 動物病院クリニック; 薬局・ドラッグストアCovering：Zoetis Inc.; Merck & Co., Inc.; Boehringer Ingelheim International Gmb; Elanco Animal Health Inc.orporated; Ceva Sante Animale

Veterinary Pharmaceuticals Global Market Opportunities And Strategies To 2032Including: 1) By Type: Veterinary Vaccines; Veterinary Antibiotics; Veterinary Parasiticides2) By Route Of Administration: Oral; Parenteral; Topical3) By Type Of Animal: Livestock; Companion Animals4) By Type Of Vaccine: Inactivated Vaccines; Attenuated Vaccines; Recombinant Vaccines5) By End User: Veterinary Hospitals; Veterinary Clinics; Pharmacies And Drug StoresCovering: Zoetis Inc.; Merck & Co., Inc.; Boehringer Ingelheim International Gmb; Elanco Animal Health Inc.orporated; Ceva Sante Animale

この調査レポートは、動物用医薬品の世界市場のビジネスチャンスと2032年までの戦略を掲載し、COVID-19の閉鎖から抜け出した世界の動物用医薬品市場を評価するために必要な重要情報を提供します。購入の理由 ... もっと見る

出版社	出版年月	電子版価格	ページ数	言語
The Business Research Company　(TBRC) ザ・ビジネスリサーチカンパニー	2023年10月10日	US$5,000 シングルユーザライセンスライセンス・価格情報注文方法はこちら	312	英語

サマリー

この調査レポートは、動物用医薬品の世界市場のビジネスチャンスと2032年までの戦略を掲載し、COVID-19の閉鎖から抜け出した世界の動物用医薬品市場を評価するために必要な重要情報を提供します。

購入の理由
- 12地域をカバーするこの市場に関する最も包括的なレポートにより、真にグローバルな視点を得ることができます。
- 市場がコロナウイルスからどのような影響を受けているのか、また、ウイルスの影響が和らぐにつれて市場がどのように立ち上がり、成長していくのかを理解することができます。
- 現地のデータと分析に基づき、地域別および国別の戦略を策定します。
- 投資の対象となる成長セグメントを特定する。
- 予測データと市場を形成するドライバーとトレンドを活用し、競合他社を凌駕する。
- 最新の市場調査結果に基づいて顧客を理解する。
- 主要な競合他社とのパフォーマンスの比較
- 主要データセット間の関係を活用し、優れた戦略を立てる。
- 信頼性の高い高品質なデータと分析により、社内外のプレゼンテーションをサポートします。

説明
動物用医薬品の最大かつ最速の成長市場はどこか？その市場は経済全体、人口動態、他の類似市場とどのように関連しているのか？今後どのような力が市場を形成していくのか？ビジネスリサーチ社の動物用医薬品市場に関する調査レポートです。

本レポートでは、市場の特徴、規模と成長、セグメンテーション、地域別および国別内訳、競合情勢、市場シェア、市場の動向と戦略を網羅しています。地域別に市場の過去および予測成長を追跡しています。また、同市場をより広範な動物用医薬品市場との関連において位置づけ、他市場との比較も行っています。

本レポートは以下の章をカバーしています：
-序論と市場の特徴
動物用医薬品市場に関する定義や解説、市場区分の簡単な紹介。
-主要動向
世界の動物用医薬品市場を形成している主なトレンドにハイライトを当てています。また、今後の市場動向についても解説しています。
-世界の市場規模と成長
世界の歴史的（2017-2022年）および予測（2022-2027年、2032F）市場価値、歴史的および予測期間における市場の成長を支え、制御する推進要因と阻害要因。
-地域別分析
地域別の過去（2017-2022年）および予測（2022-2027年、2032F）市場価値と成長率、市場シェア比較。
-市場セグメンテーション
市場におけるタイプ別、投与経路別、動物タイプ別、ワクチンタイプ別、エンドユーザー別の市場価値（2017-2022年）（2022-2027年、2032F）と各セグメント別の分析を収録。
-地域別市場規模と成長
地域別の市場規模（2022年）、過去（2017年～2022年）および予測（2022年～2027年、2032F）の市場価値、地域内の国々の成長と市場シェアの比較。アジア太平洋、西欧、東欧、北米、南米、中東、アフリカの全地域と各地域内の主要国に関する情報を掲載しています。
-競争環境
市場の競争状況、推定市場占有率、主要企業の会社プロファイルの詳細を掲載しています。
-主要なM&A
本レポートでカバーしている市場における最近のM&Aに関する情報を掲載しています。本セクションでは、近年の市場を形成したM&Aに関する主要な財務情報を提供します。
-市場機会と戦略
このセクションでは、調査結果に基づく市場機会と戦略を掲載しています。このセクションでは、国やセグメントごとの成長機会や、それらの市場で取るべき戦略に関する情報も提供しています。今後5年間で、競合他社が獲得すべき重要なビジネスがどこにあるかを理解することができる。
-結論と提言
このセクションには、調査結果に基づく結論と提言が含まれている。また、製品・サービスの提供、地理的拡大、マーケティング戦略、ターゲット層などの観点から、動物用医薬品プロバイダーへの提言も行っている。
-付録
このセクションには、本レポートで使用したNAICSコード、略語、通貨コードの詳細が含まれています。

スコープ

対象市場
1) タイプ別動物用ワクチン；動物用抗生物質；動物用寄生虫駆除薬；その他動物用医薬品
2) 投与経路別経口；非経口；局所；その他の投与経路
3) 動物の種類別家畜；コンパニオンアニマル
4) ワクチンタイプ別不活化ワクチン; 急性化ワクチン; 遺伝子組換えワクチン; その他のワクチン
5) エンドユーザー別：動物病院；動物病院；薬局・薬店

言及されている企業Zoetis Inc; Merck & Co., Inc; Boehringer Ingelheim International Gmb; Elanco Animal Health Incorporated; Ceva Sante Animale.

国中国、オーストラリア、インド、インドネシア、日本、韓国、アメリカ、ブラジル、フランス、ドイツ、イギリス、ロシア

地域アジア太平洋; 西ヨーロッパ; 東ヨーロッパ; 北アメリカ; 南アメリカ; 中東; アフリカ

時系列：過去5年間および過去10年間の予測。

データ市場規模と成長率の関連市場に対する比率、GDP比率、一人当たり支出、動物用医薬品指標の比較。

データ区分: 国別および地域別の過去データと予測データ、競合他社の市場シェア、市場セグメント。

ソーシングと参照：本レポート中のデータおよび分析は、エンドノートを使用しています。

ページTOPに戻る

1. Executive Summary
2. Table Of Contents
3. List Of Figures
4. List Of Tables
5. Report Structure
6. Introduction and Market Characteristics
6.1. General Market Definition
6.2. Summary
6.3. Veterinary Pharmaceuticals Market Definition And Segmentations
6.4. Market Segmentation By Type
6.4.1. Veterinary Vaccines
6.4.2. Veterinary Antibiotics
6.4.3. Veterinary Parasiticides
6.4.4. Other Veterinary Pharmaceuticals
6.5. Market Segmentation By Route Of Administration
6.5.1. Oral
6.5.2. Parenteral
6.5.3. Topical
6.5.4. Other Route Of Administration
6.6. Market Segmentation By Type Of Animal
6.6.1. Livestock
6.6.2. Companion Animals
6.7. Market Segmentation By Type Of Vaccine
6.7.1. Inactivated Vaccines
6.7.2. Attenuated Vaccines
6.7.3. Recombinant Vaccines
6.7.4. Other Vaccines
6.8. Market Segmentation By End User
6.8.1. Veterinary Hospitals
6.8.2. Veterinary Clinics
6.8.3. Pharmacies And Drug Stores
7. Major Market Trends
7.1. Stem Cell Therapy To Treat Animals
7.2. Application Of Nanotechnology In Veterinary Medicines To Tackle Antibiotic Resistance
7.3. Development Of Chewable Tablets
7.4. Use Of Telemedicine Platforms To Reduce The Impact Of COVID-19
7.5. Development Of Advanced Vaccines
7.6. Super-Combo Parasiticides
7.7. Use Of Subunit And Virus-Like Particle (VLP)-Based Vaccines
7.8. Strategic Partnerships And Collaborations
8. Global Market Size and Growth
8.1. Market Size
8.2. Historic Market Growth, 2017 – 2022, Value ($ Million)
8.2.1. Market Drivers 2017 – 2022
8.2.2. Increased Disease Prevalence
8.2.3. Market Restraints 2017 – 2022
8.3. Forecast Market Growth, 2022 – 2027, 2032F Value ($ Million)
8.3.1. Market Drivers 2022 – 2027
8.3.2. Market Restraints 2022 – 2027
9. Global Veterinary Pharmaceuticals Market Segmentation
9.1. Global Veterinary Pharmaceuticals Market, Segmentation By Type, Historic And Forecast, 2017 – 2022, 2027F, 2032F, Value ($ Million)
9.2. Global Veterinary Pharmaceuticals Market, Segmentation By Route Of Administration, Historic And Forecast, 2017 – 2022, 2027F, 2032F, Value ($ Million)
9.3. Global Veterinary Pharmaceuticals Market, Segmentation By Type Of Animal, Historic And Forecast, 2017 – 2022, 2027F, 2032F, Value ($ Million)
9.4. Global Veterinary Pharmaceuticals Market, Segmentation By Type Of Vaccine, Historic And Forecast, 2017 – 2022, 2027F, 2032F, Value ($ Million)
9.5. Global Veterinary Pharmaceuticals Market, Segmentation By End User, Historic And Forecast, 2017 – 2022, 2027F, 2032F, Value ($ Million)
10. Veterinary Pharmaceuticals Market, Regional and Country Analysis
10.1. Global Veterinary Pharmaceuticals Market, By Region, Historic and Forecast, 2017 – 2022, 2027F, 2032F, Value ($ Million)
10.2. Global Veterinary Pharmaceuticals Market, By Country, Historic and Forecast, 2017 – 2022, 2027F, 2032F, Value ($ Million)
11. Asia-Pacific Market
11.1. Summary
11.2. Market Overview
11.2.1. Region Information
11.2.2. Market Information
11.2.3. Background Information
11.2.4. Government Initiatives
11.2.5. Regulations
11.2.6. Regulatory Bodies
11.2.7. Major Associations
11.2.8. Taxes Levied
11.2.9. Corporate Tax Structure
11.2.10. Investments
11.2.11. Major Companies
11.3. Asia-Pacific Veterinary Pharmaceuticals Market, Historic Market Growth, 2017 – 2022, Value ($ Million)
11.4. Asia-Pacific Veterinary Pharmaceuticals Market, Forecast Market Growth, 2022 – 2027, 2032F Value ($ Million)
11.5. Asia-Pacific Veterinary Pharmaceuticals Market, Segmentation By Type, Historic And Forecast, 2017 – 2022, 2027F, 2032F, Value ($ Million)
11.6. Asia-Pacific Veterinary Pharmaceuticals Market, Segmentation By Type Of Animal, Historic And Forecast, 2017 – 2022, 2027F, 2032F, Value ($ Million)
11.7. Asia-Pacific Veterinary Pharmaceuticals Market, Segmentation By End User, Historic And Forecast, 2017 – 2022, 2027F, 2032F, Value ($ Million)
11.8. Asia-Pacific Veterinary Pharmaceuticals Market: Country Analysis
11.9. China Market
11.10. Summary
11.11. Market Overview
11.11.1. Country Information
11.11.2. Market Information
11.11.3. Background Information
11.11.4. Government Initiatives
11.11.5. Regulations
11.11.6. Regulatory Bodies
11.11.7. Major Associations
11.11.8. Taxes Levied
11.11.9. Corporate Tax Structure
11.11.10. Investments
11.11.11. Major Companies
11.12. China Veterinary Pharmaceuticals Market, Historic Market Growth, 2017 – 2022, Value ($ Million)
11.13. China Veterinary Pharmaceuticals Market, Forecast Market Growth, 2022 – 2027, 2032F Value ($ Million)
11.14. China Veterinary Pharmaceuticals Market, Segmentation By Type, Historic And Forecast, 2017 – 2022, 2027F, 2032F, Value ($ Million)
11.15. China Veterinary Pharmaceuticals Market, Segmentation By Type Of Animal, Historic And Forecast, 2017 – 2022, 2027F, 2032F, Value ($ Million)
11.16. China Veterinary Pharmaceuticals Market, Segmentation By End User, Historic And Forecast, 2017 – 2022, 2027F, 2032F, Value ($ Million)
11.17. India Market
11.18. India Veterinary Pharmaceuticals Market, Historic Market Growth, 2017 – 2022, Value ($ Million)
11.19. India Veterinary Pharmaceuticals Market, Forecast Market Growth, 2022 – 2027, 2032F Value ($ Million)
11.20. India Veterinary Pharmaceuticals Market, Segmentation By Type, Historic And Forecast, 2017 – 2022, 2027F, 2032F, Value ($ Million)
11.21. India Veterinary Pharmaceuticals Market, Segmentation By Type Of Animal, Historic And Forecast, 2017 – 2022, 2027F, 2032F, Value ($ Million)
11.22. India Veterinary Pharmaceuticals Market, Segmentation By End User, Historic And Forecast, 2017 – 2022, 2027F, 2032F, Value ($ Million)
11.23. Japan Market
11.24. Japan Veterinary Pharmaceuticals Market, Historic Market Growth, 2017 – 2022, Value ($ Million)
11.25. Japan Veterinary Pharmaceuticals Market, Forecast Market Growth, 2022 – 2027, 2032F Value ($ Million)
11.26. Japan Veterinary Pharmaceuticals Market, Segmentation By Type, Historic And Forecast, 2017 – 2022, 2027F, 2032F, Value ($ Million)
11.27. Japan Veterinary Pharmaceuticals Market, Segmentation By Type Of Animal, Historic And Forecast, 2017 – 2022, 2027F, 2032F, Value ($ Million)
11.28. Japan Veterinary Pharmaceuticals Market, Segmentation By End User, Historic And Forecast, 2017 – 2022, 2027F, 2032F, Value ($ Million)
11.29. Australia Market
11.30. Australia Veterinary Pharmaceuticals Market, Historic Market Growth, 2017 – 2022, Value ($ Million)
11.31. Australia Veterinary Pharmaceuticals Market, Forecast Market Growth, 2022 – 2027, 2032F Value ($ Million)
11.32. Australia Veterinary Pharmaceuticals Market, Segmentation By Type, Historic And Forecast, 2017 – 2022, 2027F, 2032F, Value ($ Million)
11.33. Australia Veterinary Pharmaceuticals Market, Segmentation By Type Of Animal, Historic And Forecast, 2017 – 2022, 2027F, 2032F, Value ($ Million)
11.34. Australia Veterinary Pharmaceuticals Market, Segmentation By End User, Historic And Forecast, 2017 – 2022, 2027F, 2032F, Value ($ Million)
11.35. Indonesia Market
11.36. Indonesia Veterinary Pharmaceuticals Market, Historic Market Growth, 2017 – 2022, Value ($ Million)
11.37. Indonesia Veterinary Pharmaceuticals Market, Forecast Market Growth, 2022 – 2027, 2032F Value ($ Million)
11.38. Indonesia Veterinary Pharmaceuticals Market, Segmentation By Type, Historic And Forecast, 2017 – 2022, 2027F, 2032F, Value ($ Million)
11.39. Indonesia Veterinary Pharmaceuticals Market, Segmentation By Type Of Animal, Historic And Forecast, 2017 – 2022, 2027F, 2032F, Value ($ Million)
11.40. Indonesia Veterinary Pharmaceuticals Market, Segmentation By End User, Historic And Forecast, 2017 – 2022, 2027F, 2032F, Value ($ Million)
11.41. South Korea Market
11.42. South Korea Veterinary Pharmaceuticals Market, Historic Market Growth, 2017 – 2022, Value ($ Million)
11.43. South Korea Veterinary Pharmaceuticals Market, Forecast Market Growth, 2022 – 2027, 2032F Value ($ Million)
11.44. South Korea Veterinary Pharmaceuticals Market, Segmentation By Type, Historic And Forecast, 2017 – 2022, 2027F, 2032F, Value ($ Million)
11.45. South Korea Veterinary Pharmaceuticals Market, Segmentation By Type Of Animal, Historic And Forecast, 2017 – 2022, 2027F, 2032F, Value ($ Million)
11.46. South Korea Veterinary Pharmaceuticals Market, Segmentation By End User, Historic And Forecast, 2017 – 2022, 2027F, 2032F, Value ($ Million)
12. Western Europe Market
12.1. Summary
12.2. Market Overview
12.2.1. Region Information
12.2.2. Market Information
12.2.3. Background Information
12.2.4. Government Initiatives
12.2.5. Regulations
12.2.6. Regulatory bodies
12.2.7. Major Associations
12.2.8. Taxes Levied
12.2.9. Corporate Tax Structure
12.2.10. Investments
12.2.11. Major Companies
12.3. Western Europe Veterinary Pharmaceuticals Market, Historic Market Growth, 2017 – 2022, Value ($ Million)
12.4. Western Europe Veterinary Pharmaceuticals Market, Forecast Market Growth, 2022 – 2027, 2032F Value ($ Million)
12.5. Western Europe Veterinary Pharmaceuticals Market, Segmentation By Type, Historic And Forecast, 2017 – 2022, 2027F, 2032F, Value ($ Million)
12.6. Western Europe Veterinary Pharmaceuticals Market, Segmentation By Type Of Animal, Historic And Forecast, 2017 – 2022, 2027F, 2032F, Value ($ Million)
12.7. Western Europe Veterinary Pharmaceuticals Market, Segmentation By End User, Historic And Forecast, 2017 – 2022, 2027F, 2032F, Value ($ Million)
12.8. Western Europe Veterinary Pharmaceuticals Market: Country Analysis
12.9. UK Market
12.10. UK Veterinary Pharmaceuticals Market, Historic Market Growth, 2017 – 2022, Value ($ Million)
12.11. UK Veterinary Pharmaceuticals Market, Forecast Market Growth, 2022 – 2027, 2032F Value ($ Million)
12.12. UK Veterinary Pharmaceuticals Market, Segmentation By Type, Historic And Forecast, 2017 – 2022, 2027F, 2032F, Value ($ Million)
12.13. UK Veterinary Pharmaceuticals Market, Segmentation By Type Of Animal, Historic And Forecast, 2017 – 2022, 2027F, 2032F, Value ($ Million)
12.14. UK Veterinary Pharmaceuticals Market, Segmentation By End User, Historic And Forecast, 2017 – 2022, 2027F, 2032F, Value ($ Million)
12.15. Germany Market
12.16. Germany Veterinary Pharmaceuticals Market, Historic Market Growth, 2017 – 2022, Value ($ Million)
12.17. Germany Veterinary Pharmaceuticals Market, Forecast Market Growth, 2022 – 2027, 2032F Value ($ Million)
12.18. Germany Veterinary Pharmaceuticals Market, Segmentation By Type, Historic And Forecast, 2017 – 2022, 2027F, 2032F, Value ($ Million)
12.19. Germany Veterinary Pharmaceuticals Market, Segmentation By Type Of Animal, Historic And Forecast, 2017 – 2022, 2027F, 2032F, Value ($ Million)
12.20. Germany Veterinary Pharmaceuticals Market, Segmentation By End User, Historic And Forecast, 2017 – 2022, 2027F, 2032F, Value ($ Million)
12.21. France Market
12.22. France Veterinary Pharmaceuticals Market, Historic Market Growth, 2017 – 2022, Value ($ Million)
12.23. France Veterinary Pharmaceuticals Market, Forecast Market Growth, 2022 – 2027, 2032F Value ($ Million)
12.24. France Veterinary Pharmaceuticals Market, Segmentation By Type, Historic And Forecast, 2017 – 2022, 2027F, 2032F, Value ($ Million)
12.25. France Veterinary Pharmaceuticals Market, Segmentation By Type Of Animal, Historic And Forecast, 2017 – 2022, 2027F, 2032F, Value ($ Million)
12.26. France Veterinary Pharmaceuticals Market, Segmentation By End User, Historic And Forecast, 2017 – 2022, 2027F, 2032F, Value ($ Million)
13. Eastern Europe Market
13.1. Summary
13.2. Market Overview
13.2.1. Region Information
13.2.2. Market Information
13.2.3. Background Information
13.2.4. Government Initiatives
13.2.5. Regulations
13.2.6. Regulatory Bodies
13.2.7. Major Associations
13.2.8. Taxes levied
13.2.9. Corporate Tax Structure
13.2.10. Investments
13.2.11. Major Companies
13.3. Eastern Europe Veterinary Pharmaceuticals Market, Historic Market Growth, 2017 – 2022, Value ($ Million)
13.4. Eastern Europe Veterinary Pharmaceuticals Market, Forecast Market Growth, 2022 – 2027, 2032F Value ($ Million)
13.5. Eastern Europe Veterinary Pharmaceuticals Market, Segmentation By Type, Historic And Forecast, 2017 – 2022, 2027F, 2032F, Value ($ Million)
13.6. Eastern Europe Veterinary Pharmaceuticals Market, Segmentation By Type Of Animal, Historic And Forecast, 2017 – 2022, 2027F, 2032F, Value ($ Million)
13.7. Eastern Europe Veterinary Pharmaceuticals Market, Segmentation By End User, Historic And Forecast, 2017 – 2022, 2027F, 2032F, Value ($ Million)
13.8. Eastern Europe Veterinary Pharmaceuticals Market: Country Analysis
13.9. Russia Market
13.10. Russia Veterinary Pharmaceuticals Market, Historic Market Growth, 2017 – 2022, Value ($ Million)
13.11. Russia Veterinary Pharmaceuticals Market, Forecast Market Growth, 2022 – 2027, 2032F Value ($ Million)
13.12. Russia Veterinary Pharmaceuticals Market, Segmentation By Type, Historic And Forecast, 2017 – 2022, 2027F, 2032F, Value ($ Million)
13.13. Russia Veterinary Pharmaceuticals Market, Segmentation By Type Of Animal, Historic And Forecast, 2017 – 2022, 2027F, 2032F, Value ($ Million)
13.14. Russia Veterinary Pharmaceuticals Market, Segmentation By End User, Historic And Forecast, 2017 – 2022, 2027F, 2032F, Value ($ Million)
14. North America Market
14.1. Summary
14.2. Market Overview
14.2.1. Region Information
14.2.2. Market Information
14.2.3. Background Information
14.2.4. Government Initiatives
14.2.5. Regulations
14.2.6. Regulatory Bodies
14.2.7. Major Associations
14.2.8. Taxes Levied
14.2.9. Corporate Tax Structure
14.2.10. Investments
14.2.11. Major Companies
14.3. North America Veterinary Pharmaceuticals Market, Historic Market Growth, 2017 – 2022, Value ($ Million)
14.4. North America Veterinary Pharmaceuticals Market, Forecast Market Growth, 2022 – 2027, 2032F Value ($ Million)
14.5. North America Veterinary Pharmaceuticals Market, Segmentation By Type, Historic And Forecast, 2017 – 2022, 2027F, 2032F, Value ($ Million)
14.6. North America Veterinary Pharmaceuticals Market, Segmentation By Type Of Animal, Historic And Forecast, 2017 – 2022, 2027F, 2032F, Value ($ Million)
14.7. North America Veterinary Pharmaceuticals Market, Segmentation By End User, Historic And Forecast, 2017 – 2022, 2027F, 2032F, Value ($ Million)
14.8. North America Veterinary Pharmaceuticals Market: Country Analysis
14.9. USA Market
14.10. Summary
14.11. Market Overview
14.11.1. Region Information
14.11.2. Market Information
14.11.3. Background Information
14.11.4. Government Initiatives
14.11.5. Regulations
14.11.6. Regulatory Bodies
14.11.7. Major Associations
14.11.8. Taxes Levied
14.11.9. Corporate Tax Structure
14.11.10. Investments
14.11.11. Major Companies
14.12. USA Veterinary Pharmaceuticals Market, Historic Market Growth, 2017 – 2022, Value ($ Million)
14.13. USA Veterinary Pharmaceuticals Market, Forecast Market Growth, 2022 – 2027, 2032F Value ($ Million)
14.14. USA Veterinary Pharmaceuticals Market, Segmentation By Type, Historic And Forecast, 2017 – 2022, 2027F, 2032F, Value ($ Million)
14.15. USA Veterinary Pharmaceuticals Market, Segmentation By Type Of Animal, Historic And Forecast, 2017 – 2022, 2027F, 2032F, Value ($ Million)
14.16. USA Veterinary Pharmaceuticals Market, Segmentation By End User, Historic And Forecast, 2017 – 2022, 2027F, 2032F, Value ($ Million)
15. South America Market
15.1. Summary
15.2. Market Overview
15.2.1. Region Information
15.2.2. Market Information
15.2.3. Background Information
15.2.4. Government Initiatives
15.2.5. Regulations
15.2.6. Regulatory Bodies
15.2.7. Major Associations
15.2.8. Taxes Levied
15.2.9. Corporate Tax Structure
15.2.10. Investments
15.2.11. Major Companies
15.3. South America Veterinary Pharmaceuticals Market, Historic Market Growth, 2017 – 2022, Value ($ Million)
15.4. South America Veterinary Pharmaceuticals Market, Forecast Market Growth, 2022 – 2027, 2032F Value ($ Million)
15.5. South America Veterinary Pharmaceuticals Market, Segmentation By Type, Historic And Forecast, 2017 – 2022, 2027F, 2032F, Value ($ Million)
15.6. South America Veterinary Pharmaceuticals Market, Segmentation By Type Of Animal, Historic And Forecast, 2017 – 2022, 2027F, 2032F, Value ($ Million)
15.7. South America Veterinary Pharmaceuticals Market, Segmentation By End User, Historic And Forecast, 2017 – 2022, 2027F, 2032F, Value ($ Million)
15.8. South America Veterinary Pharmaceuticals Market: Country Analysis
15.9. Brazil Market
15.10. Brazil Veterinary Pharmaceuticals Market, Historic Market Growth, 2017 – 2022, Value ($ Million)
15.11. Brazil Veterinary Pharmaceuticals Market, Forecast Market Growth, 2022 – 2027, 2032F Value ($ Million)
15.12. Brazil Veterinary Pharmaceuticals Market, Segmentation By Type, Historic And Forecast, 2017 – 2022, 2027F, 2032F, Value ($ Million)
15.13. Brazil Veterinary Pharmaceuticals Market, Segmentation By Type Of Animal, Historic And Forecast, 2017 – 2022, 2027F, 2032F, Value ($ Million)
15.14. Brazil Veterinary Pharmaceuticals Market, Segmentation By End User, Historic And Forecast, 2017 – 2022, 2027F, 2032F, Value ($ Million)
16. Middle East Market
16.1. Summary
16.2. Market Overview
16.2.1. Region Information
16.2.2. Market Information
16.2.3. Background Information
16.2.4. Government Initiatives
16.2.5. Regulations
16.2.6. Regulatory Bodies
16.2.7. Major Associations
16.2.8. Taxes Levied
16.2.9. Corporate Tax Structure
16.2.10. Investments
16.2.11. Major Companies
16.3. Middle East Veterinary Pharmaceuticals Market, Historic Market Growth, 2017 – 2022, Value ($ Million)
16.4. Middle East Veterinary Pharmaceuticals Market, Forecast Market Growth, 2022 – 2027, 2032F Value ($ Million)
16.5. Middle East Veterinary Pharmaceuticals Market, Segmentation By Type, Historic And Forecast, 2017 – 2022, 2027F, 2032F, Value ($ Million)
16.6. Middle East Veterinary Pharmaceuticals Market, Segmentation By Type Of Animal, Historic And Forecast, 2017 – 2022, 2027F, 2032F, Value ($ Million)
16.7. Middle East Veterinary Pharmaceuticals Market, Segmentation By End User, Historic And Forecast, 2017 – 2022, 2027F, 2032F, Value ($ Million)
17. Africa Market
17.1. Summary
17.2. Market Overview
17.2.1. Region Information
17.2.2. Market Information
17.2.3. Background Information
17.2.4. Government Initiatives
17.2.5. Regulations
17.2.6. Regulatory Bodies
17.2.7. Major Associations
17.2.8. Taxes Levied
17.2.9. Corporate Tax Structure
17.2.10. Investments
17.2.11. Major Companies
17.3. Africa Veterinary Pharmaceuticals Market, Historic Market Growth, 2017 – 2022, Value ($ Million)
17.4. Africa Veterinary Pharmaceuticals Market, Forecast Market Growth, 2022 – 2027, 2032F Value ($ Million)
17.5. Africa Veterinary Pharmaceuticals Market, Segmentation By Type, Historic And Forecast, 2017 – 2022, 2027F, 2032F, Value ($ Million)
17.6. Africa Veterinary Pharmaceuticals Market, Segmentation By Type Of Animal, Historic And Forecast, 2017 – 2022, 2027F, 2032F, Value ($ Million)
17.7. Africa Veterinary Pharmaceuticals Market, Segmentation By End User, Historic And Forecast, 2017 – 2022, 2027F, 2032F, Value ($ Million)
18. Competitive Landscape And Company Profiles
18.1. Company Profiles
18.2. Zoetis Inc
18.2.1. Company Overview
18.2.2. Products And Services
18.2.3. Business Strategy
18.2.4. Financial Overview
18.3. Merck & Co., Inc.
18.3.1. Company Overview
18.3.2. Products And Services
18.3.3. Business Strategy
18.3.4. Financial Overview
18.4. Boehringer Ingelheim International GmbH
18.4.1. Company Overview
18.4.2. Products And Services
18.4.3. Business Strategy
18.4.4. Financial Overview
18.5. Elanco Animal Health Incorporated
18.5.1. Company Overview
18.5.2. Products And Services
18.5.3. Business Strategy
18.5.4. Financial Overview
18.6. Ceva Santé Animale
18.6.1. Company Overview
18.6.2. Products And Services
18.6.3. Business Strategy
18.6.4. Financial Overview
19. Key Mergers and Acquisitions
19.1. EQT Acquired Dechra Pharmaceuticals
19.2. Wedgewood Pharmacy Merged With Blue Rabbit
19.3. Sun Pharmaceutical Acquired A Majority Stake In Vivaldis Health and Foods
19.4. Orion Corporation Acquired VMD NV
19.5. Zendal Group Acquired Maymo
19.6. Mitsui Acquired Sumitomo Pharma Animal Health
19.7. Zoetis Acquired Jurox
19.8. Vimian Group Acquired Heiland GmbH
19.9. Dechra Acquired Med-Pharmex
19.10. Bimeda Acquired Afrivet
19.11. Dechra Pharmaceuticals Acquired Piedmont Animal Health
19.12. Virbac Acquired Assets Of Elanco Animal Health Inc.
19.13. Vetoquinol Acquired Australian Assets Of Elanco Animal Health Inc.
19.14. Swedencare AB Acquired Animal Pharmaceuticals Inc.
19.15. Elanco Animal Health Acquired Bayer Animal Health
19.16. MSD Animal Health Acquired Worldwide Rights of VECOXAN from Elanco Health
19.17. Boehringer Ingelheim Acquired Global Stem Cell Technology
19.18. Merck & Co. Inc. Announced The Acquisition Of Virbac’s Anti-Parasitic Portfolio
19.19. The Carlyle Group Acquired SeQuent Scientific Ltd.
19.20. Friulchem Acquired Pharmabbie
19.21. Manna Pro Acquired Promika, LLC Pet Brands
20. Opportunities And Strategies
20.1. Global Veterinary Pharmaceuticals Market In 2027 – Countries Offering Most New Opportunities
20.2. Global Veterinary Pharmaceuticals Market In 2027 – Segments Offering Most New Opportunities
20.3. Global Veterinary Pharmaceuticals Market In 2027 – Growth Strategies
20.3.1. Market Trend Based Strategies
20.3.2. Competitor Strategies
21. Veterinary Pharmaceuticals Market, Conclusions And Recommendations
21.1. Conclusions
21.2. Recommendations
21.2.1. Product
21.2.2. Place
21.2.3. Price
21.2.4. Promotion
21.2.5. People
22. Appendix
22.1. Market Data Sources
22.2. Research Methodology
22.3. Currencies
22.4. The Business Research Company
22.5. Copyright and Disclaimer

ページTOPに戻る

Table of Contents

Summary

Veterinary Pharmaceuticals Global Market Opportunities And Strategies To 2032 from The Business Research Company provides the strategists; marketers and senior management with the critical information they need to assess the global veterinary pharmaceuticals market as it emerges from the COVID-19 shut down.

Reasons to Purchase
• Gain a truly global perspective with the most comprehensive report available on this market covering 12 geographies.
• Understand how the market is being affected by the coronavirus and how it is likely to emerge and grow as the impact of the virus abates.
• Create regional and country strategies on the basis of local data and analysis.
• Identify growth segments for investment.
• Outperform competitors using forecast data and the drivers and trends shaping the market.
• Understand customers based on the latest market research findings.
• Benchmark performance against key competitors.
• Utilize the relationships between key data sets for superior strategizing.
• Suitable for supporting your internal and external presentations with reliable high-quality data and analysis

Description:
Where is the largest and fastest growing market for veterinary pharmaceuticals? How does the market relate to the overall economy; demography and other similar markets? What forces will shape the market going forward? The veterinary pharmaceuticals market global report from The Business Research Company answers all these questions and many more.

The report covers market characteristics; size and growth; segmentation; regional and country breakdowns; competitive landscape; market shares; trends and strategies for this market. It traces the market’s historic and forecast market growth by geography. It places the market within the context of the wider veterinary pharmaceuticals market; and compares it with other markets.

The report covers the following chapters:
•Introduction and Market Characteristics
Brief introduction to the segmentations covered in the market, definitions and explanations about the veterinary pharmaceuticals market.
•Key Trends
Highlights the major trends shaping the global veterinary pharmaceuticals market. This section also highlights likely future developments in the market.
•Global Market Size and Growth
Global historic (2017-2022) and forecast (2022-2027, 2032F) market values, and drivers and restraints that support and control the growth of the market in the historic and forecast periods.
•Regional Analysis
Historic (2017-2022) and forecast (2022-2027, 2032F) market values and growth and market share comparison by region.
•Market Segmentation
Contains the market values (2017-2022) (2022-2027, 2032F) and analysis for each segment by type, by route of administration, by type of animal, by type of vaccine and by end user in the market.
•Regional Market Size and Growth
Regional market size (2022), historic (2017-2022) and forecast (2022-2027, 2032F) market values, and growth and market share comparison of countries within the region. This report includes information on all the regions Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East and Africa and major countries within each region.
•Competitive Landscape
Details on the competitive landscape of the market, estimated market shares and company profiles of the leading players.
•Key Mergers and Acquisitions
Information on recent mergers and acquisitions in the market covered in the report. This section gives key financial details of mergers and acquisitions, which have shaped the market in recent years.
•Market Opportunities And Strategies
This section includes market opportunities and strategies based on findings of the research. This section also gives information on growth opportunities across countries, segments and strategies to be followed in those markets. It gives an understanding of where there is significant business to be gained by competitors in the next five years.
•Conclusions And Recommendations
This section includes conclusions and recommendations based on findings of the research. This section also gives recommendations for veterinary pharmaceuticals providers in terms of product/service offerings, geographic expansion, marketing strategies and target group.
•Appendix
This section includes details on the NAICS codes covered, abbreviations and currencies codes used in this report.

Scope:

Markets Covered:
1) By Type: Veterinary Vaccines; Veterinary Antibiotics; Veterinary Parasiticides; Other Veterinary Pharmaceuticals
2) By Route Of Administration: Oral; Parenteral; Topical; Other Routes Of Administration
3) By Type Of Animal: Livestock; Companion Animals
4) By Type Of Vaccine: Inactivated Vaccines; Attenuated Vaccines; Recombinant Vaccines; Other Vaccines
5) By End User: Veterinary Hospitals; Veterinary Clinics; Pharmacies And Drug Stores

Companies Mentioned: Zoetis Inc; Merck & Co., Inc; Boehringer Ingelheim International Gmb; Elanco Animal Health Incorporated; Ceva Sante Animale.

Countries: China; Australia; India; Indonesia; Japan; South Korea; USA; Brazil; France; Germany; UK; Russia

Regions: Asia-Pacific; Western Europe; Eastern Europe; North America; South America; Middle East; Africa

Time series: Five years historic and ten years forecast.

Data: Ratios of market size and growth to related markets; GDP proportions; expenditure per capita; veterinary pharmaceuticals indicators comparison.

Data segmentations: country and regional historic and forecast data; market share of competitors; market segments.

Sourcing and Referencing: Data and analysis throughout the report is sourced using end notes.

ページTOPに戻る

ご注文は、お電話またはWEBから承ります。お見積もりの作成もお気軽にご相談ください。

webからのご注文・お問合せはこちらのフォームから承ります

本レポートと同分野（医療）の最新刊レポート

The Business Research Company　(TBRC)社の動物向け医療分野での最新刊レポート

本レポートと同じKEY WORD（administration）の最新刊レポート

よくあるご質問

The Business Research Company　(TBRC)社はどのような調査会社ですか?

The Business Research Company (TBRC)はインドを主要拠点に世界の多様な市場を調査・予測し、調査レポートを積極的に出版しています。調査対象には技術、ライフサイエンス、重... もっと見る

調査レポートの納品までの日数はどの程度ですか?

在庫のあるものは速納となりますが、平均的には 3-４日と見て下さい。
但し、一部の調査レポートでは、発注を受けた段階で内容更新をして納品をする場合もあります。
発注をする前のお問合せをお願いします。

注文の手続きはどのようになっていますか?

1)お客様からの御問い合わせをいただきます。
2)見積書やサンプルの提示をいたします。
3)お客様指定、もしくは弊社の発注書をメール添付にて発送してください。
4)データリソース社からレポート発行元の調査会社へ納品手配します。
5) 調査会社からお客様へ納品されます。最近は、pdfにてのメール納品が大半です。

お支払方法の方法はどのようになっていますか?

納品と同時にデータリソース社よりお客様へ請求書（必要に応じて納品書も）を発送いたします。
お客様よりデータリソース社へ（通常は円払い）の御振り込みをお願いします。
請求書は、納品日の日付で発行しますので、翌月最終営業日までの当社指定口座への振込みをお願いします。振込み手数料は御社負担にてお願いします。
お客様の御支払い条件が60日以上の場合は御相談ください。
尚、初めてのお取引先や個人の場合、前払いをお願いすることもあります。ご了承のほど、お願いします。

データリソース社はどのような会社ですか?

当社は、世界各国の主要調査会社・レポート出版社と提携し、世界各国の市場調査レポートや技術動向レポートなどを日本国内の企業・公官庁及び教育研究機関に提供しております。
世界各国の「市場・技術・法規制などの」実情を調査・収集される時には、データリソース社にご相談ください。
お客様の御要望にあったデータや情報を抽出する為のレポート紹介や調査のアドバイスも致します。

サマリー

目次

Summary

Table of Contents

ご注文は、お電話またはWEBから承ります。お見積もりの作成もお気軽にご相談ください。

本レポートと同分野（医療）の最新刊レポート

The Business Research Company (TBRC)社の動物向け医療分野での最新刊レポート

本レポートと同じKEY WORD（administration）の最新刊レポート

よくあるご質問

The Business Research Company (TBRC)社はどのような調査会社ですか?

調査レポートの納品までの日数はどの程度ですか?

注文の手続きはどのようになっていますか?

お支払方法の方法はどのようになっていますか?

データリソース社はどのような会社ですか?

The Business Research Company　(TBRC)社の動物向け医療分野での最新刊レポート

The Business Research Company　(TBRC)社はどのような調査会社ですか?